Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More
U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618871) titled 'Prefabricated CAD/CAM PEEK Crowns For Primary Molars Restoration' on May 22. Brief Summary:... Read More
U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07619222) titled 'Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Pati... Read More
U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617428) titled 'Clinical Validation of a Blood Loss Monitoring System' on May 05. Brief Summary: This obser... Read More
U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07616531) titled 'Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevent... Read More